Cetyltrimethylammonium Bromide Disrupts the Mesenchymal Characteristics of HA22T/VGH Cells<i>Via</i>Inactivation of c-Met/PI3K/Akt/mTOR PathwayChia-Herng Yue, CHIA-JEN LEE|Anticancer Research|2020Cited by 5
Cetyltrimethylammonium Bromide Disrupts Mesenchymal Characteristics of Human Tongue Squamous Cell Carcinoma SCC4 Cells Through Modulating Canonical TGF-β/Smad/miR-181b/TIMP3 Signaling PathwayChia-Herng Yue, CHIA-JEN LEE|Anticancer Research|2021Cited by 4